Are there clinical trials for relapsed or refractory peripheral t cell lymphoma?

Yes. Clin2 currently lists 1,731 recruiting relapsed or refractory peripheral t cell lymphoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.

How do I know if I qualify for a relapsed or refractory peripheral t cell lymphoma trial?

Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Does it cost anything to join a relapsed or refractory peripheral t cell lymphoma trial?

Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.

Clinical trials

Relapsed or Refractory Peripheral T Cell Lymphoma clinical trials

Below are recruiting relapsed or refractory peripheral t cell lymphoma clinical trials, each written for real people, not researchers. We’re tracking 1,731 recruiting studies, each written for real people, not researchers, below.

Search relapsed or refractory peripheral t cell lymphoma trials near you

Recruiting studies

NCT06027879Enrolling by invitationPhase 1/Phase 2
Anti-viral T-cell therapy for stubborn viral infections after transplant
This trial tests a treatment using specially grown T-cells (a type of immune cell) to fight certain viruses that won't go away with standard medicines. It is for people who have had a stem cell or organ transplant, or who have a weak immune system, and who are struggling with adenovirus, CMV, or EBV infections.
Pittsburgh, PennsylvaniaAges 1 month–65 years
NCT05706220Enrolling by invitation
Eye tests to measure visual speed in multiple sclerosis
This study tests how fast and how accurately your eyes process visual information and how eye movements look in people with multiple sclerosis. It may help researchers understand vision-related effects of MS using objective eye measurements.
Valladolid, ValladolidAges 18–80
NCT05336188Enrolling by invitation
Smartphone help to prevent relapse in opioid use disorder
This study looks at whether a smartphone-based program can help people avoid relapse from opioid use disorder. Some participants may also do brain scans to better understand the brain changes behind relapse prevention.
Little Rock, ArkansasAges 18 years+

Hear when a new Relapsed or Refractory Peripheral T Cell Lymphoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.

Common questions

Are there clinical trials for relapsed or refractory peripheral t cell lymphoma?: Yes. Clin2 currently lists 1,731 recruiting relapsed or refractory peripheral t cell lymphoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
How do I know if I qualify for a relapsed or refractory peripheral t cell lymphoma trial?: Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Does it cost anything to join a relapsed or refractory peripheral t cell lymphoma trial?: Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.

Related conditions

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.

Recruiting studies

Anti-viral T-cell therapy for stubborn viral infections after transplant

Eye tests to measure visual speed in multiple sclerosis

Smartphone help to prevent relapse in opioid use disorder

Common questions

Related conditions